AADI
Income statement / Annual
Last year (2024), Aadi Bioscience, Inc.'s total revenue was $25.98 M,
an increase of 6.69% from the previous year.
In 2024, Aadi Bioscience, Inc.'s net income was -$63.69 M.
See Aadi Bioscience, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$25.98 M |
$24.35 M |
$15.22 M |
$1.12 M |
$14.00 M |
$749.00 K |
$20.16 M |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$3.02 M
|
$2.81 M
|
$1.34 M
|
$276.00 K
|
$176.00 K
|
$76.50 K
|
$0.00
|
$51.27 K
|
$69.67 K
|
$57.98 K
|
| Gross Profit |
$22.96 M
|
$21.55 M
|
$13.88 M
|
-$18.55 M
|
$13.82 M
|
$672.50 K
|
$20.16 M
|
-$51.27 K
|
-$69.67 K
|
-$57.98 K
|
| Gross Profit Ratio |
0.88
|
0.88
|
0.91
|
-16.56
|
0.99
|
0.9
|
1
|
0
|
0
|
0
|
| Research and Development Expenses |
$51.03 M
|
$48.93 M
|
$32.66 M
|
$19.67 M
|
$15.01 M
|
$12.82 M
|
$17.85 M
|
$12.15 M
|
$11.37 M
|
$11.63 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$18.51 M
|
$2.12 M
|
$1.85 M
|
$13.49 M
|
$9.24 M
|
$29.49 K
|
$23.01 K
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$7.83 M
|
-$46.69 K
|
-$51.27 K
|
$5.17 M
|
$5.78 M
|
| Selling, General & Administrative Expenses |
$36.75 M
|
$44.55 M
|
$40.18 M
|
$18.51 M
|
$2.12 M
|
$9.68 M
|
$13.44 M
|
$9.19 M
|
$5.20 M
|
$5.80 M
|
| Other Expenses |
$2.64 M
|
$0.00
|
$0.00
|
$54.49 M
|
-$176.00 K
|
$0.00
|
-$6.39 K
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$90.42 M
|
$93.48 M
|
$72.84 M
|
$92.67 M
|
$16.95 M
|
$22.50 M
|
$31.29 M
|
$21.34 M
|
$16.56 M
|
$17.43 M
|
| Cost And Expenses |
$93.44 M
|
$96.29 M
|
$77.90 M
|
$112.22 M
|
$17.13 M
|
$22.58 M
|
$31.34 M
|
$21.39 M
|
$16.63 M
|
$17.49 M
|
| Interest Income |
$3.93 M
|
$6.40 M
|
$2.40 M
|
$13.00 K
|
$41.00 K
|
$1.03 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$154.00 K
|
$231.00 K
|
$230.00 K
|
$665.00 K
|
$815.00 K
|
$0.00
|
$778.22 K
|
-$105.78 K
|
$9.94 K
|
$8.43 K
|
| Depreciation & Amortization |
$193.00 K
|
$169.00 K
|
$159.00 K
|
$276.00 K
|
$176.00 K
|
$76.50 K
|
$46.69 K
|
$51.27 K
|
$69.67 K
|
$57.98 K
|
| EBITDA |
-$64.63 M |
-$65.37 M |
-$60.12 M |
-$109.15 M |
-$2.49 M |
-$24.44 M |
-$10.35 M |
-$21.24 M |
-$16.43 M |
-$17.01 M |
| EBITDA Ratio |
-2.49
|
-2.68
|
-3.95
|
-97.45
|
-0.18
|
-32.64
|
-0.51
|
0
|
0
|
0
|
| Operating Income Ratio |
-2.6
|
-2.95
|
-3.87
|
-99.3
|
-0.18
|
-30.15
|
-0.55
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$3.77 M
|
$6.17 M
|
$2.17 M
|
$1.13 M
|
-$927.00 K
|
$1.17 M
|
$784.61 K
|
-$12.07 K
|
-$349.93 K
|
$416.33 K
|
| Income Before Tax |
-$63.69 M
|
-$65.77 M
|
-$60.51 M
|
-$110.09 M
|
-$3.48 M
|
-$23.27 M
|
-$10.40 M
|
-$21.40 M
|
-$16.98 M
|
-$17.07 M
|
| Income Before Tax Ratio |
-2.45
|
-2.7
|
-3.98
|
-98.29
|
-0.25
|
-31.07
|
-0.52
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$2.00 K
|
$2.00 K
|
$1.30 K
|
$0.00
|
-$12.06 K
|
-$3.00
|
$3.00
|
| Net Income |
-$63.69 M
|
-$65.77 M
|
-$60.51 M
|
-$110.09 M
|
-$3.48 M
|
-$23.27 M
|
-$10.40 M
|
-$21.40 M
|
-$16.98 M
|
-$17.07 M
|
| Net Income Ratio |
-2.45
|
-2.7
|
-3.98
|
-98.29
|
-0.25
|
-31.07
|
-0.52
|
0
|
0
|
0
|
| EPS |
-2.36 |
-2.44 |
-2.69 |
-12.41 |
-26.34 |
-8.6 |
-3.3 |
-14.81 |
-9.42 |
-9.47 |
| EPS Diluted |
-2.36 |
-2.44 |
-2.69 |
-12.41 |
-26.34 |
-8.6 |
-4.6 |
-14.81 |
-9.42 |
-9.47 |
| Weighted Average Shares Out |
$26.99 M
|
$26.92 M
|
$22.51 M
|
$8.92 M
|
$169.49 K
|
$2.71 M
|
$3.15 M
|
$1.44 M
|
$1.80 M
|
$1.80 M
|
| Weighted Average Shares Out Diluted |
$27.03 M
|
$26.92 M
|
$22.51 M
|
$8.92 M
|
$169.49 K
|
$2.71 M
|
$2.26 M
|
$1.44 M
|
$1.80 M
|
$1.80 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
